Drug name - Noctiva
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7579321 | SERENITY PHARMS LLC | Pharmaceutical compositions including low dosages of desmopressin |
May, 2023
(7 months from now) | |
| US7405203 | SERENITY PHARMS LLC | Pharmaceutical compositions including low dosages of desmopressin |
May, 2023
(7 months from now) | |
| US7799761 | SERENITY PHARMS LLC | Pharmaceutical compositions including low dosages of desmopressin |
Sep, 2024
(1 year, 11 months from now) | |
| US9539302 | SERENITY PHARMS LLC | Safe desmopressin administration |
Jun, 2030
(7 years from now) | |
Drugs and Companies using DESMOPRESSIN ACETATE ingredient
Treatment: A method of treating nocturia due to nocturnal polyuria in adults
Dosage: SPRAY, METERED;NASAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.00083MG/SPRAY | SPRAY, METERED;NASAL | Discontinued |
| 0.00166MG/SPRAY | SPRAY, METERED;NASAL | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.